The gap between shorter- and longer-dated U.S. borrowing costs is widening, reflecting investors’ conviction that the Federal ...

Dow Jones futures edged lower Monday morning, along with S&P 500 futures and Nasdaq futures. TeslaTSLA, Micron TechnologyMU and AppLovinAPP are near buy points with Federal Reserve chief Jerome Powell ...

U.S. stock futures are lower after last week's gains on increased expectations for a Federal Reserve rate cut in September.

Goldman's David Kostin sifted through earnings season, and one thing he noticed was that guidance for the rest of the year ...

UnitedHealth extends gains while Dayforce soars following a report that says it could be bought by private-equity firm Thoma ...

The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a form of liver disease.

Fresh off a 12% surge on the news that Warren Buffett's Berkshire Hathaway, as well as other leading investors, purchased the ...

The Shenzhen Composite Index added 1.8% to close at its strongest level since early 2022, while the Nasdaq-like ChiNext Price Index climbed 2.8% to its highest close in more than two and a half years.

U.S. stock futures showed little movement ahead of a critical Washington meeting between President Donald Trump and Ukrainian ...

--Asian stock markets ended mixed. Taiwan's Taiex closed at a record high powered by TSMC, the world's largest contract chip maker. Its shares rose 16.5% in the second quarter and are up 11% so far in ...

Novo Nordisk shares (DK:NOVO.B) (NVO) rose 4% in Copenhagen trade. The stock however has plunged 46% this year amid increased competition for its weight-loss drugs as well as turmoil at the company.